Live Quote · NASDAQPHATHealthcare· Biotechnology

Phathom Pharmaceuticals, Inc.

$4.66▼ 8.27%($-0.42)
MKT CAP $378.82MNEXT EARNINGS Feb 25, 2027
50%
Bullish
TickerSpark Score
62/100
▌ Mixed
60
Valuation
40
Profitability
100
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHAT research report →

Analyst Price Target
$16.50+254.1% vs. today

Range $10 – $22

Analyst RatingBuy
8 Buy1 Hold0 Sell

Price Chart

-67.55% · this period
$18.08$11.37$4.66Nov 20May 26Nov 20
52-Week Range0% of range
Low
$4.62
Current
$4.66
High
$18.31